This makes semaglutide an effective option for not only managing type 2 diabetes but also supporting significant weight loss
Please call, text, or email us if you have any questions
*Correspondence: Chen Chen, [email protected] Guo, [email protected] These authors have contributed equally to this work This article was submitted to Molecular Signalling and Pathways, a section of the journal Frontiers in Molecular Neuroscience Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
In fact, emerging evidence indicates strong signals in favor of GLP-1 receptor agonists for reducing cancer risk in select malignancies, although the current literature is limited
One of the biggest studies to draw attention looked at adults with overweight or obesity and established cardiovascular disease, but without diabetes